MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

511096

Report Date :

28.05.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

BEXIMCO PHARMACEUTICALS LIMITED

 

 

Registered Office :

19, Dhanmondi R/A, Road# 7, Dhaka-1205

 

 

Country :

Bangladesh

 

 

Financials (as on) :

31.03.2018 [Summarized]

 

 

Date of Incorporation :

1976

 

 

Com. Reg. No.:

C-4744

 

 

Legal Form :

Public Listed Company

 

 

Line of Business :

Manufacturer, Distributor, Exporter and Importer of Pharmaceutical Finished Formulation Products, Large Volume Parenteral and Active Pharmaceutical Ingredients (APIs)

 

 

No. of Employees :

3,000

 


 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

Bangladesh

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

BANGLADESH - ECONOMIC OVERVIEW

 

Bangladesh's economy has grown roughly 6% per year since 2005 despite prolonged periods of political instability, poor infrastructure, endemic corruption, insufficient power supplies, and slow implementation of economic reforms. Although more than half of GDP is generated through the services sector, almost half of Bangladeshis are employed in the agriculture sector, with rice as the single-most-important product.

Garment exports, the backbone of Bangladesh's industrial sector, accounted for more than 80% of total exports and surpassed $28 billion in FY 2016-17. The sector continues to grow despite the need for improvements in factory safety conditions and workers’ rights to avert further high-profile accidents that killed more than 1,000 workers in 2012 and 2013. In FY 2016-17, steady export growth in the garment sector, combined with $13 billion in remittances from overseas Bangladeshis, contributed to Bangladesh's rising foreign exchange reserves.

The recent influx of over 700,000 additional refugees from Burma will place pressure on the Bangladeshi government’s budget and the country’s rice supplies, which declined in 2017 in part because of record flooding. Recent improvements to energy infrastructure, including the start of liquefied natural gas imports in 2018, represent a major step forward in resolving a key growth bottleneck.

 

Source : CIA

 


Company name

 

BEXIMCO PHARMACEUTICALS LIMITED

   

 

EXECUTIVE SUMMARY

 

IDENTIFICATION DETAILS

Correct company Name

:

Beximco Pharmaceuticals Limited

Head Office

:

19, Dhanmondi R/A, Road# 7, Dhaka-1205, Bangladesh.

Tel No

:

88-02-58611001-7

Fax No

:

88-02-58613888, 58644601

E-mail

:

info@bpl.net

Website

:

www.beximcopharma.com

Date/ Year of Incorporation

:

1976

Incorporation No.

:

C-4744

Legal Form (General)

:

 Public Listed Co      Public (but not listed)   Private Co   State-owned Co

 Sole Proprietorships  Partnership            Not Registered

 others (please specify) ________________

Legal form (Specific)

:

LTD   CORP    INC  CO    

 others (please specify) ________________

Issuing Authority

:

Registrar of Joint Stock Companies & Firms   City Corporation

 Municipal Administration                 Union Council

 Cantonment Board                       Chief Controller of  Import & Export (CCIE)

 

 

Other Registry & Certification Details

 

Organization Name

:

Bangladesh Aushad Shilpa Samity

Membership No

:

N/A

 

 

FINANCIALS- SUMMARY

      Year

Turnover/ Sales

 Assets

     Income

30th June’2017

BDT 11444599000

(July 2016 - Mar 2017)

BDT 34084133000

BDT 1634447000

(July 2016 - Mar 2017)

31st March’2018

BDT 12859563000

(July 2017 - Mar 2018)

BDT 38949780000

BDT 1920508000

(July 2017 - Mar 2018)

 

 

FULLCHECK REPORT DETAILS

 

Information Parted By

Name

:

Mr. Afsar Uddin Ahmed

Designation

:

Director (Commercial)

Contract No

:

N/A

 

Locations Details

Operating address

:

19, Dhanmondi R/A, Road# 7, Dhaka-1205, Bangladesh.

Tel No

:

88-02-58611001-7

E-mail

:

88-02-58613888, 58644601

Fax No

:

info@bpl.net

Website

:

www.beximcopharma.com

 

Location :

: Owned

Ö

 

Rented

 

 

Leased

 

Area

6500

Sq. ft.

 

Type of Office :

  :       Commercial Office Bldg.

Ö

 

Semi-commercial office Bldg.

 

     

 

Retail shop

 

 

Industrial Park

 

     

 

Business Center

 

 

Home Office

 

     

 

Residential Bldg.

 

 

 

 

 

 

Factory Address (Unit-1):

 

 

 

Address

:

126, Kathaldia, Tongi, Gazipur, Bangladesh.

Tel No

:

Nil

Fax No

:

Nil

 

Factory Address (Unit-2):

 

 

 

Address

:

Plot# 1070/1083, Mouchak, Kaliakoir, Gazipur, Bangladesh.

Tel No

:

Nil

Fax No

:

Nil

 

Corporate Head Office Address:

 

 

 

Address

:

17, Dhanmondi R/A, Road# 2, Dhaka-1205, Bangladesh.

Tel No

:

88-02-58611891, 5861040

Fax No

:

88-02-58613470, 9615523

 

Branch Address-1:

 

 

 

Address

:

BEL Tower (Level-10), Road# 1, 19, Dhanmondi R/A,  Dhaka-1205,

Bangladesh.

Tel No

:

88-02-58611891, 5861040

Fax No

:

88-02-58613470, 9615523

 

Branch Address-2:

 

 

 

Address

:

House# 62, Road# 7/A, Dhaka-1205, Bangladesh.

Tel No

:

Nil

Fax No

:

Nil

 

Employee:

 

 

 

No. of Employees 

 

In Office

:

4,00

In Factory

:

2,600

In Branch:

:

Nil

Total

:

3,000

Details:

 

                    

 

 

 

OWNERSHIP/SHAREHOLDERS

 

Names of Shareholders

No. of Share

Country

A S F Rahman

8235353

Bangladesh.

Salman F Rahman

8254632

Bangladesh.

Associates and Other Directors

36979784

Bangladesh.

Foreign Investors

168084988

Bangladesh.

ICB & Other Investors Account

46191780

Bangladesh.

General Public & Institutions

137809908

Bangladesh.

 

 

DIRECTORS

 

Name

:

Mr. Ahmed Sohail Fasiur Rahman

Designation

:

Chairman

Nationality

:

Bangladeshi.

Email address

:

N/A

Other details

:

N/A

 

 

 

 

 

Name

:

Mr. Ahmed Salman Fazlur Rahman

Designation

:

Vice Chairman

Nationality

:

Bangladeshi.

Email address

:

N/A

Other details

:

N/A

 

 

 

 

 

Name

:

Mr. Nazmul Hassan MP

Designation

:

Managing Director

Nationality

:

Bangladeshi.

Email address

:

N/A

Other details

:

N/A

 

 

 

 

 

Name

:

Mr. Iqbal Ahmed

Designation

:

Director

Nationality

:

Bangladeshi.

Email address

:

N/A

Other details

:

N/A

 

 

 

 

 

Name

:

Mr. Osman Kaiser Chowdhury

Designation

:

Director

Nationality

:

Bangladeshi.

Email address

:

N/A

Other details

:

N/A

 

 

6.

 

 

 

Name

:

Mr. Abu Bakar Siddiqur Rahman

Designation

:

Director

Nationality

:

Bangladeshi.

Email address

:

N/A

Other details

:

N/A

 

7.

 

 

 

Name

:

Mr. Shah Monjurul Hoque

Designation

:

Independent Director

Nationality

:

Bangladeshi.

Email address

:

N/A

Other details

:

N/A

 

8.

 

 

 

Name

:

Mr. Abdur Rahman Khan

Designation

:

Independent Director

Nationality

:

Bangladeshi.

Email address

:

N/A

Other details

:

N/A

 

 

MANAGEMENT

 

Name

:

Mr. Nazmul Hassan MP

Job Description

:

Managing Director

Nationality

:

Bangladeshi

Email address

:

Nil

Other details

:

Nil

 

Name

:

Mr. Afsar Uddin Ahmed

Job Description

:

Director (Commercial)

Nationality

:

Bangladeshi

Email address

:

Nil

Other details

:

Nil

 

Name

:

Mr. Mohammad Asad Ullah, FCS

Job Description

:

Company Secretary & Executive Director

Nationality

:

Bangladeshi

Email address

:

Nil

Other details

:

Nil

 

Name

:

Mr. Ali Nawaz

Job Description

:

Chief Financial Officer

Nationality

:

Bangladeshi

Email address

:

Nil

Other details

:

Nil

 

 

BUSINESS OPERATIONS

 

Nature of Activity       :

Manufacturer

Ö

Trader

 

Dealer

 

Distributor

Ö

 

 

 

Exporter

Ö

Importer

Ö

Services

 

Others

 

 

Range of Products:

 

Products

:

Pharmaceutical Finished Formulation Products, Large Volume Parenteral

and Active Pharmaceutical Ingredients (APIs)

Production Capacity

:

10 MW

Registered Production

:

400

 

Trading Terms:

 

Purchasing Terms:

L/C

Ö

Cash

 

Others

 

 

 

Credit :

 

30 days

 

60 days

Ö

90 days

 

 

days

 

Selling Terms      :

L/C

 

Cash

Ö

Others

 

 

 

Credit :

Ö

30 days

 

60 days

 

90 days

 

 

days

 

 

DETAILED DATA

Trade Reference & Related Parties

:

 

Overseas Clients

:

Nil

 

Local Clients

:

Local Peoples

 

Overseas Suppliers

:

Nil

 

Local Suppliers

:

Nil

 

Trade Markets

:

 

Exports(Country)

:

USA, Europe, Australia, Canada, Latin America and South Africa.

 

Imports(Country)

:

China, Malaysia, India, Pakistan

 

Brand Name

:

N/A

Certified

:

N/A

Name of Auditors

:

M.J. Abedin & Co

Chartered Accountants

Operation Status

:

Active

 

 

CAPITAL STRUCTURE

 

Authorized Capital

:

BDT 5000 Million

 

Paid-up Capital

:

BDT 4055564000

 

No. of Shares

:

405556400

 

Share Value

:

BDT10.00Each

 

Main Assets

:

BDT 38949780000

 

 

FINANCIAL STATEMENT- DETAILED

 

Balance Sheet:

 

  Currency

BDT

 

       Denomination

: ‘000’

 

         Financial Year Ending

: 31st Mar’2018

     Financial Highlights

31st Mar’2018

     30th June’2017

ASSETS

 

 

Non-Current Assets

28,209,565

24,953,317

Property, Plant and Equipment- Carrying Value

27,639,687

24,472,468

Intangible Assets

532,412

462,969

Investment in Shares

37,466

17,880

Current Assets

10,740,215

9,130,816

Inventories

3,773,316

3,468,089

Spares & Supplies

629,283

636,103

Accounts Receivable

2,544,771

2,167,340

Loans, Advances and Deposits

2,767,944

1,697,679

Short Term Investment

336,615

886,577

Cash and Cash Equivalents

688,286

275,028

TOTAL ASSETS

38,949,780

34,084,133

EQUITY AND LIABILITIES

 

 

Shareholders’ Equity

26,466,237

25,072,426

Issued Share Capital

4,055,564

4,055,564

Share Premium

5,269,475

5,269,475

Excess of Issue Price over Face Value of GDRs

1,689,637

1,689,637

Capital Reserve on Merger

294,951

294,951

Revaluation Surplus

1,161,225

1,190,204

Unrealized Gain/(Loss)

5,315

3,875

Retained Earnings

13,990,070

12,568,720

Non-Current Liabilities

7,721,214

5,605,667

Long Term Borrowings-Net off Current Maturity (Secured) 8 A

4,652,717

2,635,907

Liability for Gratuity and WPPF & Welfare Funds

1,190,614

1,117,094

Deferred Tax Liability

1,877,883

1,852,666

Current Liabilities and Provisions

4,762,329

3,406,040

Short Term Borrowings (Secured)

1,962,741

1,239,758

Long Term Borrowings-Current Maturity

(Secured)

665,906

715,790

Creditors and Other Payables

1,255,483

783,839

Accrued Expenses

458,192

245,375

Dividend Payable

5,250

353

Income Tax Payable

414,757

420,925

TOTAL EQUITY AND LIABILITIES

38,949,780

34,084,133

 

Income Statement :

 

  Currency

: BDT

 

       Denomination

: ‘000’

 

         Financial Year Ending

: 31st Mar’2018

     Financial Highlights

July’2017~ Mar’2018

July’2016~ Mar’2017

Net Sales Revenue

12,859,563

11,444,599

Cost Of Goods Sold

(6,872,812)

(6,105,068)

Gross Profit

5,986,751

5,339,531

Operating Expenses

(3,066,839)

(2,754,843)

Administrative Expenses

(442,986)

(404,631)

Selling, Marketing And Distribution Expenses

(2,623,853)

(2,350,212)

Profit From Operations

2,919,912

2,584,688

Other Income

40,569

136,798

Finance Cost

(304,547)

(466,063)

Profit Before Contribution To WPPF & Welfare Funds

2,655,934

2,255,423

Contribution To WPPF & Welfare Funds

(126,473)

(107,401)

Profit Before Tax

2,529,461

2,148,022

Income Tax Expenses

(608,953)

(513,575)

Current Tax

(604,928)

(490,894)

Deferred Tax

(4,025)

(22,681)

Profit After Tax

1,920,508

1,634,447

Other Comprehensive Income-Unrealized

Gain/(Loss)

1,440

2,167

Total Comprehensive Income

1,921,948

1,636,614

 

 

ASSOCIARES/SUBSIDIARIES/ RELATED PARTIES

 

Sister Concerns

:

Bextrade Ltd.

Sonali Ansh Ltd.

GMG Airlines Ltd.

Bangladesh Online

Essess Fashions Ltd.

Beximco Media Ltd.

Beximco Apparels Ltd.

Beximco Fashions Ltd.

Beximco Holdings Ltd.

Beximco Securities Ltd.

Beximco Petroleum Ltd.

Beximco Synthetics Ltd.

Beximco Computers Ltd.

Shinepukur Ceramics Ltd.

Pharmatek Chemicals Ltd.

Beximco Engineering Ltd

New Dacca Industries Limited                          

Bangladesh Export Import Co Ltd.

Bangladesh Antibiotics Industries Ltd.

Crescent Fashion And Design Limited 

International Knitwear & Apparels Ltd.

Beximco Property Development And Management Limited

Subsidiary

:

N/A

Name of  The Group

:

Beximco Group 

 

 

BANKING

 

Bank Name  

:

Janata Bank Ltd.

Bank Address

:

Local Office Branch

1, Dilkusha Commercial Area, Dhaka-1000, Bangladesh

Tel: 88-02-9553106, 9556241

Fax: 88-02-9563639

 

 

ADVERSE DATA MONITORING

 

Dishonored Checks          

:     

No Record Found         

Debt

 

:

No Record Found

Litigation  

                    

:

Clear         

Performance Defaults

 

:

No Record Found         

Adverse Local Media Coverage/ Adverse Filling History

:

No Record Found

 

 

SITE VISIT COMMENTARY

 

Our Representative Visited the subject company Head office which is situated at 19, Dhanmondi R/A, Road # 7, Dhaka-1205, Bangladesh. It is situated at Residential Area.

 

 

GENERAL COMMENTS

 

Based on the financial statements, SC’s financial performance appears to be Strong manufacturer, Importer & Exporter. SC has been in its line of business for about 16 years.

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

INR 68.26

UK Pound

1

INR 91.22

Euro

1

INR 79.88

BDT

1

INR 0.80

 

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

NIS

 

 

Report Prepared by :

SYL

                                                


 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.